Tags

Type your tag names separated by a space and hit enter

A history of leprosy in Iran during the 19th and 20th centuries.
Arch Iran Med. 2011 Nov; 14(6):425-30.AI

Abstract

From ancient time leprosy has been regarded as a terrifying, stigmatized disease; nevertheless, its cause remained unidentified up to the late 19th century. For centuries numerous leprosy victims worldwide suffered from its morbidity and were socially isolated. The afflicted individuals were segregated because they were considered 'unclean' and had to live in leper colonies, generally under very poor conditions. Physicians believed that leprosy was an incurable, highly contagious, and hereditary disease. In 1873 the Norwegian physician, Gerhard Armauer Hansen (1841-1912), ended the myth of leprosy and discovered its causative agent, known as Mycobacterium leprae. Hansen's discovery was a great triumph in the fight against leprosy. In the 1930's, the first effective antileprosy drug, dapsone, was introduced and in the early 1980's multi-drug therapy was popularized because of high efficacy in resistant cases. Here, we have presented a brief look at the history of leprosy in the world with special focus on the historical account of leprosy in Iran, particularly during the 19th and 20th centuries.

Authors+Show Affiliations

Academy of Medical Sciences of the I.R. of Iran, Tehran, Iran. azizi@ams.ac.irNo affiliation info available

Pub Type(s)

Historical Article
Journal Article

Language

eng

PubMed ID

22039850

Citation

Azizi, Mohammad Hossein, and Moslem Bahadori. "A History of Leprosy in Iran During the 19th and 20th Centuries." Archives of Iranian Medicine, vol. 14, no. 6, 2011, pp. 425-30.
Azizi MH, Bahadori M. A history of leprosy in Iran during the 19th and 20th centuries. Arch Iran Med. 2011;14(6):425-30.
Azizi, M. H., & Bahadori, M. (2011). A history of leprosy in Iran during the 19th and 20th centuries. Archives of Iranian Medicine, 14(6), 425-30. https://doi.org/011146/AIM.0014
Azizi MH, Bahadori M. A History of Leprosy in Iran During the 19th and 20th Centuries. Arch Iran Med. 2011;14(6):425-30. PubMed PMID: 22039850.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A history of leprosy in Iran during the 19th and 20th centuries. AU - Azizi,Mohammad Hossein, AU - Bahadori,Moslem, PY - 2011/11/2/entrez PY - 2011/11/2/pubmed PY - 2012/3/10/medline SP - 425 EP - 30 JF - Archives of Iranian medicine JO - Arch Iran Med VL - 14 IS - 6 N2 - From ancient time leprosy has been regarded as a terrifying, stigmatized disease; nevertheless, its cause remained unidentified up to the late 19th century. For centuries numerous leprosy victims worldwide suffered from its morbidity and were socially isolated. The afflicted individuals were segregated because they were considered 'unclean' and had to live in leper colonies, generally under very poor conditions. Physicians believed that leprosy was an incurable, highly contagious, and hereditary disease. In 1873 the Norwegian physician, Gerhard Armauer Hansen (1841-1912), ended the myth of leprosy and discovered its causative agent, known as Mycobacterium leprae. Hansen's discovery was a great triumph in the fight against leprosy. In the 1930's, the first effective antileprosy drug, dapsone, was introduced and in the early 1980's multi-drug therapy was popularized because of high efficacy in resistant cases. Here, we have presented a brief look at the history of leprosy in the world with special focus on the historical account of leprosy in Iran, particularly during the 19th and 20th centuries. SN - 1735-3947 UR - https://www.unboundmedicine.com/medline/citation/22039850/A_history_of_leprosy_in_Iran_during_the_19th_and_20th_centuries_ L2 - http://www.ams.ac.ir/AIM/NEWPUB/11/14/6/0014.pdf DB - PRIME DP - Unbound Medicine ER -